These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 15390044)

  • 1. Hallucinations in Parkinson's disease: a follow-up study.
    de Maindreville AD; Fénelon G; Mahieux F
    Mov Disord; 2005 Feb; 20(2):212-7. PubMed ID: 15390044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REM behavior disorder, hallucinations and cognitive impairment in Parkinson's disease: a two-year follow up.
    Sinforiani E; Pacchetti C; Zangaglia R; Pasotti C; Manni R; Nappi G
    Mov Disord; 2008 Jul; 23(10):1441-5. PubMed ID: 18512749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations.
    Santangelo G; Trojano L; Vitale C; Ianniciello M; Amboni M; Grossi D; Barone P
    Mov Disord; 2007 Dec; 22(16):2418-25. PubMed ID: 17894370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual plus nonvisual hallucinations in Parkinson's disease: development and evolution over 10 years.
    Goetz CG; Stebbins GT; Ouyang B
    Mov Disord; 2011 Oct; 26(12):2196-200. PubMed ID: 21755536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients.
    Goetz CG; Wuu J; Curgian L; Leurgans S
    Mov Disord; 2006 Feb; 21(2):267-70. PubMed ID: 16161144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hallucinations in Parkinson's disease--a study of forty three patients.
    Gupta M; Singh G; Khwaja GA; Mehndiratta MM
    J Assoc Physicians India; 2004 Sep; 52():703-6. PubMed ID: 15839446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease.
    Pacchetti C; Manni R; Zangaglia R; Mancini F; Marchioni E; Tassorelli C; Terzaghi M; Ossola M; Martignoni E; Moglia A; Nappi G
    Mov Disord; 2005 Nov; 20(11):1439-48. PubMed ID: 16028215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hallucinations and sleep disorders in PD: six-year prospective longitudinal study.
    Goetz CG; Wuu J; Curgian LM; Leurgans S
    Neurology; 2005 Jan; 64(1):81-6. PubMed ID: 15642908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of dementia and visual hallucinations in tremor and non-tremor dominant Parkinson's disease.
    Rana AQ; Vaid HM; Edun A; Dogu O; Rana MA
    J Neurol Sci; 2012 Dec; 323(1-2):158-61. PubMed ID: 23062324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive changes in Parkinson's disease patients with visual hallucinations.
    Ramirez-Ruiz B; Junque C; Marti MJ; Valldeoriola F; Tolosa E
    Dement Geriatr Cogn Disord; 2007; 23(5):281-8. PubMed ID: 17351320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up.
    Onofrj M; Thomas A; D'Andreamatteo G; Iacono D; Luciano AL; Di Rollo A; Di Mascio R; Ballone E; Di Iorio A
    Neurol Sci; 2002 Sep; 23 Suppl 2():S91-4. PubMed ID: 12548359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired visual acuity as a risk factor for visual hallucinations in Parkinson's disease.
    Matsui H; Udaka F; Tamura A; Oda M; Kubori T; Nishinaka K; Kameyama M
    J Geriatr Psychiatry Neurol; 2006 Mar; 19(1):36-40. PubMed ID: 16449759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's disease.
    Sinforiani E; Zangaglia R; Manni R; Cristina S; Marchioni E; Nappi G; Mancini F; Pacchetti C
    Mov Disord; 2006 Apr; 21(4):462-6. PubMed ID: 16228998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of hallucinations in Parkinson's disease using a novel scale.
    Wada-Isoe K; Ohta K; Imamura K; Kitayama M; Nomura T; Yasui K; Nakaso K; Nakashima K
    Acta Neurol Scand; 2008 Jan; 117(1):35-40. PubMed ID: 18095953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: Positive impact on long-term worsening.
    Goetz CG; Fan W; Leurgans S
    Mov Disord; 2008 Aug; 23(11):1541-5. PubMed ID: 18567004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attentional and perceptual impairments in Parkinson's disease with visual hallucinations.
    Koerts J; Borg MA; Meppelink AM; Leenders KL; van Beilen M; van Laar T
    Parkinsonism Relat Disord; 2010 May; 16(4):270-4. PubMed ID: 20153970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment patterns in Parkinson's disease with visual hallucinations.
    Ozer F; Meral H; Hanoglu L; Ozturk O; Aydemir T; Cetin S; Atmaca B; Tiras R
    J Clin Neurosci; 2007 Aug; 14(8):742-6. PubMed ID: 17544275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for hallucinations in Parkinson's disease: results from a large prospective cohort study.
    Zhu K; van Hilten JJ; Putter H; Marinus J
    Mov Disord; 2013 Jun; 28(6):755-62. PubMed ID: 23520046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations.
    van Laar T; Postma AG; Drent M
    Parkinsonism Relat Disord; 2010 Jan; 16(1):71-2. PubMed ID: 19524477
    [No Abstract]   [Full Text] [Related]  

  • 20. Frontal dysfunction contributes to the genesis of hallucinations in non-demented Parkinsonian patients.
    Grossi D; Trojano L; Pellecchia MT; Amboni M; Fragassi NA; Barone P
    Int J Geriatr Psychiatry; 2005 Jul; 20(7):668-73. PubMed ID: 16021658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.